United Kingdom

With an eye on Brexit, there’s contingency money for the JET nuclear fusion facility, and tweaks to the visa system in bid to attract more researchers from outside the EU

Outcome-based pricing of cancer drugs could provide savings for payers and patients, but generating enough data on benefits remains a big challenge

The freedom, and perils, of a plan to build a rival to Galileo and the US global positioning system

Science establishment complains about lack of clear guidance; calls for more detailed planning

Time from patent to patient has increased by more than a year, Institute of Cancer Research finds in new study

All parties in the negotiations on the UK’s departure from the EU must now strive to ensure that as little harm as possible is done to research, say 29 Nobel prize winners in letter to May and Juncker